Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
{ "products": [ { "_id": "69c3af3e5b76c936a0276e2f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Lobeglitazone Sulfate 0.5 mg", "description": "LOBEGLITONE 0.5 is an advanced oral anti-diabetic medication containing Lobeglitazone Sulfate 0.5 mg, developed for the effective management of Type 2 Diabetes Mellitus. In today’s fast-paced lifestyle, diabetes has become a widespread metabolic disorder that requires long-term control to prevent serious complications. LOBEGLITONE 0.5 is designed to improve insulin sensitivity and help maintain optimal blood glucose levels in adults.\n\nBelonging to the thiazolidinedione (TZD) class of drugs, Lobeglitazone works at the cellular level to enhance the body’s response to insulin. It is particularly beneficial for patients who struggle with insulin resistance, a key factor in Type 2 diabetes. With its potent action and improved safety profile, LOBEGLITONE 0.5 offers a reliable option for modern diabetes care.\n\nComposition Overview\n\nEach tablet of LOBEGLITONE 0.5 contains:\n\nLobeglitazone Sulfate equivalent to Lobeglitazone 0.5 mg\n\nThis low-dose yet highly effective formulation ensures better glycemic control with minimal risk when used appropriately under medical supervision.\n\nHow It Works\n\nLOBEGLITONE 0.5 works by targeting insulin resistance, one of the main causes of Type 2 diabetes. It activates PPAR-γ (Peroxisome Proliferator-Activated Receptor Gamma) receptors found in fat cells, muscle tissue, and the liver.\n\nThrough this mechanism:\n\nThe body becomes more sensitive to insulin\nGlucose uptake by cells increases\nExcess glucose production in the liver decreases\n\nAs a result, blood sugar levels are effectively controlled without directly increasing insulin secretion, reducing the risk of sudden hypoglycemia.\n\nUses of LOBEGLITONE 0.5\n1. Management of Type 2 Diabetes Mellitus\n\nLOBEGLITONE 0.5 is primarily used to control blood glucose levels in adults with Type 2 diabetes, especially in cases where insulin resistance is significant.\n\n2. Combination Therapy\n\nIt can be used along with other anti-diabetic medications such as:\n\nMetformin\nSulfonylureas\nDPP-4 inhibitors\n\nThis combination approach helps achieve better glycemic control when a single drug is not sufficient.\n\n3. Long-Term Diabetes Control\n\nHelps reduce the risk of long-term complications such as nerve damage, kidney disease, and cardiovascular issues when used consistently.\n\nKey Benefits\n✔ Improves Insulin Sensitivity\n\nEnhances the body’s natural ability to use insulin effectively, addressing the root cause of Type 2 diabetes.\n\n✔ Stable Blood Sugar Control\n\nProvides consistent glycemic control without sudden spikes or drops.\n\n✔ Low Risk of Hypoglycemia\n\nSince it does not stimulate insulin secretion directly, the risk of low blood sugar is minimal.\n\n✔ Supports Lipid Profile\n\nMay help improve cholesterol levels by reducing triglycerides and increasing good HDL cholesterol.\n\n✔ Once-Daily Convenience\n\nSimple dosing improves patient compliance and ease of long-term use.\n\n✔ Effective in Resistant Cases\n\nIdeal for patients who do not respond adequately to first-line therapies.\n\nDirections for Use\nTake LOBEGLITONE 0.5 exactly as prescribed by your healthcare provider.\nUsually taken once daily, with or without food.\nSwallow the tablet whole with water.\nMaintain a balanced diet and regular exercise routine for best results.\n\nImportant: Do not stop or change the dosage without consulting your doctor.\n\nPossible Side Effects\n\nLOBEGLITONE 0.5 is generally well tolerated, but some individuals may experience side effects.\n\nCommon Side Effects\nWeight gain\nMild swelling (edema)\nHeadache\nMuscle pain\nLess Common Side Effects\nUpper respiratory tract infections\nFatigue\nIncreased appetite\nRare but Serious Side Effects\nFluid retention leading to heart-related issues\nLiver function abnormalities\nBone fractures (with long-term use in some patients)\n\nIf any severe or persistent symptoms occur, immediate medical attention is advised.\n\nPrecautions\nNot recommended for patients with severe heart failure.\nUse cautiously in individuals with liver disorders.\nRegular monitoring of blood glucose and liver function is essential.\nInform your doctor about any existing medical conditions or medications.\nPregnant and breastfeeding women should use only if prescribed.\nStorage Instructions\nStore in a cool and dry place below 25°C\nKeep away from moisture and direct sunlight\nKeep out of reach of children\nLifestyle Recommendations\n\nFor optimal results with LOBEGLITONE 0.5, patients should:\n\nFollow a diabetic-friendly diet\nEngage in regular physical activity\nMonitor blood sugar levels consistently\nAvoid smoking and limit alcohol intake\n\nThese lifestyle modifications enhance the effectiveness of the medication and promote overall health.\n\nConclusion\n\nLOBEGLITONE 0.5 (Lobeglitazone Sulfate 0.5 mg) represents a modern and effective solution for managing Type 2 diabetes, particularly in patients with insulin resistance. Its targeted mechanism, combined with a favorable safety profile, makes it a valuable addition to diabetes treatment regimens.", "price": 86.0, "discountamount": 60.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2353, "imageuri": "https://productimages.withfloats.com/actual/69c3af403b4966c256447629.png", "tileimageuri": "https://productimages.withfloats.com/tile/69c3af403b4966c256447629.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-25T09:47:42.831Z", "updatedon": "2026-03-25T09:47:42.831Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lobeglitazone-sulfate-0-5-mg/2353", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LOBEGLITONE 0.5", "category": "DIABETIC RANGE", "tags": [ "lobeglitazone sulfate 0.5 mg tablet uses", "lobeglitazone 0.5 mg for type 2 diabetes treatment", "lobeglitazone sulfate dosage and benefits", "lobeglitazone tablet for blood sugar management", "lobeglitazone 0.5 mg daily dose effectiveness", "lobeglitazone 0.5 mg price in india", "lobeglitazone 0.5 mg price in india", "lobeglitazone sulfate 0.5 mg for insulin resistance in type 2 diabetes india", "lobeglitazone tzds class drug for blood sugar control", "oral lobeglitazone sulfate tablets for diabetes management" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69affd814f6df2ce02d820ab", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metformin Hydrochloride Prolonged Release", "description": "Metformin Hydrochloride Prolonged Release Tablets for Effective Blood Sugar Control\n\nManaging diabetes requires a combination of proper medication, a balanced lifestyle, and regular monitoring of blood glucose levels. For individuals living with type 2 diabetes, maintaining stable blood sugar levels is essential to prevent complications and ensure overall health. SEIZMET 500, formulated with Metformin Hydrochloride Prolonged Release, is a trusted oral medication designed to help control blood sugar levels in adults diagnosed with type 2 diabetes mellitus.\n\nSEIZMET 500 works by improving the body's response to insulin and reducing the amount of glucose produced by the liver. Its prolonged-release formulation allows the medicine to work gradually throughout the day, providing consistent blood sugar control while reducing gastrointestinal discomfort that may occur with immediate-release forms of metformin.\n\nThis medication is widely recommended by healthcare professionals as a first-line treatment for type 2 diabetes, especially for patients who need effective glycemic control along with long-term metabolic support.\n\nProduct Description\n\nSEIZMET 500 is an oral antidiabetic medication containing Metformin Hydrochloride in a prolonged-release formulation. Metformin belongs to a class of medicines known as biguanides, which are commonly prescribed to manage type 2 diabetes.\n\nUnlike many diabetes medications that stimulate the pancreas to produce more insulin, Metformin works through multiple mechanisms that improve the body’s natural ability to regulate blood sugar. It reduces excess glucose production in the liver, increases insulin sensitivity, and enhances the uptake of glucose by muscles and tissues.\n\nThe prolonged-release (PR) technology used in SEIZMET 500 ensures that the medicine is released slowly into the bloodstream over time. This gradual release helps maintain stable blood sugar levels throughout the day and minimizes sudden spikes or fluctuations in glucose levels.\n\nSEIZMET 500 is typically prescribed along with dietary modifications, exercise, and regular monitoring of blood glucose levels to achieve optimal diabetes management.\n\nComposition\n\nEach tablet of SEIZMET 500 contains:\n\nMetformin Hydrochloride Prolonged Release – 500 mg\n\nThis controlled-release formulation provides sustained therapeutic action and improved patient tolerance.\n\nUses of SEIZMET 500\n\nSEIZMET 500 is primarily used for the treatment and management of type 2 diabetes mellitus. It helps control blood sugar levels in individuals whose glucose levels cannot be adequately managed through lifestyle changes alone.\n\n1. Treatment of Type 2 Diabetes\n\nThe primary use of SEIZMET 500 is to manage elevated blood sugar levels in adults diagnosed with type 2 diabetes.\n\n2. Improving Glycemic Control\n\nThe medication helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic stability.\n\n3. Supporting Insulin Sensitivity\n\nMetformin enhances the body's sensitivity to insulin, allowing cells to use glucose more effectively for energy.\n\n4. Prevention of Diabetes Complications\n\nBy maintaining proper blood sugar levels, SEIZMET 500 may help reduce the risk of complications such as nerve damage, kidney disease, vision problems, and cardiovascular conditions.\n\n5. Management of Insulin Resistance\n\nMetformin is known for its ability to reduce insulin resistance, which is a major factor contributing to type 2 diabetes.\n\nHow SEIZMET 500 Works\n\nSEIZMET 500 works through several mechanisms that help control blood glucose levels:\n\nReduces Liver Glucose Production\nThe liver produces glucose even when the body does not need it. Metformin helps decrease this excessive glucose production.\n\nImproves Insulin Sensitivity\nThe medication helps body tissues respond better to insulin, allowing glucose to enter cells more efficiently.\n\nEnhances Glucose Utilization\nMuscles and other tissues use glucose more effectively for energy.\n\nDecreases Intestinal Glucose Absorption\nMetformin slows down the absorption of glucose from the digestive tract after meals.\n\nThe prolonged-release technology ensures that these actions occur steadily throughout the day.\n\nKey Benefits of SEIZMET 500\n1. Effective Blood Sugar Control\n\nSEIZMET 500 helps maintain healthy blood glucose levels, reducing the risk of hyperglycemia.\n\n2. Sustained Drug Release\n\nThe prolonged-release formulation provides gradual drug release, ensuring consistent therapeutic effects.\n\n3. Lower Risk of Hypoglycemia\n\nUnlike some diabetes medications, metformin rarely causes dangerously low blood sugar when used alone.\n\n4. Improved Insulin Sensitivity\n\nSEIZMET 500 improves the body's response to insulin, allowing glucose to be used more efficiently.\n\n5. Supports Long-Term Diabetes Management\n\nRegular use helps maintain stable glucose levels and supports overall metabolic health.\n\n6. Reduced Gastrointestinal Side Effects\n\nThe prolonged-release formulation helps minimize stomach-related side effects commonly associated with immediate-release metformin.\n\n7. Weight-Neutral or Weight-Friendly\n\nMetformin may help prevent weight gain and in some cases may support mild weight reduction, which can benefit people with type 2 diabetes.\n\nHow to Use SEIZMET 500\n\nTo achieve the best results, SEIZMET 500 should be taken according to the instructions provided by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with meals to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush, chew, or break the prolonged-release tablet.\n\nFollow the dosage and schedule prescribed by your doctor.\n\nMaintain a healthy diet and regular exercise routine.\n\nConsistency in taking the medication is essential for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, SEIZMET 500 may cause side effects in some individuals. Most side effects are mild and temporary, especially during the early stages of treatment.\n\nCommon Side Effects\n\nNausea\n\nDiarrhea\n\nStomach upset\n\nLoss of appetite\n\nMild abdominal discomfort\n\nThese symptoms often improve as the body adjusts to the medication.\n\nLess Common Side Effects\n\nMetallic taste in the mouth\n\nVitamin B12 deficiency with long-term use\n\nMild weakness or fatigue\n\nRare but Serious Side Effects\n\nLactic acidosis, a rare but serious condition associated with metformin use in patients with severe kidney problems\n\nSevere allergic reactions\n\nIf symptoms such as unusual muscle pain, difficulty breathing, severe weakness, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking SEIZMET 500, inform your healthcare provider if you have:\n\nKidney disease\n\nLiver disorders\n\nHeart conditions\n\nSevere infections\n\nA history of alcohol abuse\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nRegularly monitor blood sugar levels.\n\nAttend routine medical checkups.\n\nInform your doctor about any other medications you are taking.\n\nLifestyle Recommendations for Better Results\n\nMedication alone may not be enough to manage diabetes effectively. Individuals taking SEIZMET 500 should also focus on healthy lifestyle habits such as:\n\nMaintaining a balanced and nutritious diet\n\nEngaging in regular physical activity\n\nMonitoring blood sugar levels regularly\n\nMaintaining a healthy body weight\n\nFollowing medical advice and attending regular health checkups\n\nThese steps help maximize the benefits of the medication and support overall health.\n\nConclusion\n\nType 2 diabetes is a long-term condition that requires consistent management to maintain healthy blood sugar levels and prevent complications. SEIZMET 500, containing Metformin Hydrochloride Prolonged Release, offers an effective and reliable treatment option for individuals seeking better glucose control.", "price": 31.0, "discountamount": 9.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2324, "imageuri": "https://productimages.withfloats.com/actual/69affdab1344531582e8f29c.png", "tileimageuri": "https://productimages.withfloats.com/tile/69affdab1344531582e8f29c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T11:16:17.511Z", "updatedon": "2026-03-14T12:11:16.322Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-hydrochloride-prolonged-release/2324", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SEIZMET 500", "category": "DIABETIC RANGE", "tags": [ "metformin hydrochloride prolonged release tablets", "metformin hydrochloride slow release tablets", "prolonged release metformin 500 mg tablets", "metformin hcl pr tablets for diabetes", "metformin hydrochloride controlled release tablet", "metformin hydrochloride 1000 mg prolonged release", "diabetes management tablets metformin prolonged release", "medicine for type 2 diabetes metformin pr tablets", "slow release metformin tablets for high blood sugar", "extended release metformin tablets for blood sugar management", "metformin hydrochloride extended release for insulin resistance", "buy metformin hydrochloride prolonged release tablets", "metformin pr tablets price", "SEIZMET 500 metformin hydrochloride prolonged release price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69afcdd7726d81b4833817a9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "metformin linagliptin", "description": "Advanced Combination Therapy with Metformin and Linagliptin for Effective Blood Sugar Control\n\nManaging type 2 diabetes requires consistent care, the right medication, and lifestyle management to maintain healthy blood glucose levels. Modern diabetes treatment often uses combination therapies that work through different mechanisms to provide better control and long-term health benefits. LINALIGOLD M 2.5/1000 is a scientifically formulated anti-diabetic medication that combines Metformin (1000 mg) and Linagliptin (2.5 mg) to help manage blood sugar levels effectively in adults with type 2 diabetes mellitus.\n\nThis dual-action tablet is designed to improve glycemic control when diet and exercise alone are not sufficient. By targeting different pathways involved in glucose regulation, LINALIGOLD M 2.5/1000 helps maintain stable blood sugar levels, supports metabolic health, and reduces the risk of diabetes-related complications.\n\nProduct Description\n\nLINALIGOLD M 2.5/1000 is a combination anti-diabetic medication that brings together two well-established drugs used in diabetes management: Metformin, a biguanide that reduces glucose production in the liver and improves insulin sensitivity, and Linagliptin, a DPP-4 inhibitor that enhances the body’s natural ability to regulate blood sugar levels.\n\nThis powerful combination works synergistically to control blood glucose levels throughout the day. While Metformin helps decrease the amount of sugar released into the bloodstream from the liver, Linagliptin increases the activity of incretin hormones, which stimulate insulin release when blood sugar levels are high.\n\nLINALIGOLD M 2.5/1000 is commonly prescribed for patients with type 2 diabetes mellitus who require improved glycemic control and who may not achieve adequate results with a single medication.\n\nKey Ingredients and Their Role\nMetformin (1000 mg)\n\nMetformin is one of the most widely used medications for the treatment of type 2 diabetes. It works primarily by:\n\nReducing glucose production in the liver\n\nImproving the body's sensitivity to insulin\n\nIncreasing glucose uptake by muscle cells\n\nReducing absorption of glucose from the intestines\n\nThese actions help lower fasting and post-meal blood sugar levels while supporting overall metabolic balance.\n\nLinagliptin (2.5 mg)\n\nLinagliptin belongs to a class of medications known as DPP-4 inhibitors. It works by increasing levels of incretin hormones in the body, which help regulate blood glucose levels. Its actions include:\n\nStimulating insulin release after meals\n\nReducing excessive glucose production by the liver\n\nLowering postprandial (after meal) blood sugar levels\n\nSupporting natural glucose regulation without causing sudden drops in blood sugar\n\nTogether, these two ingredients provide a comprehensive approach to diabetes management.\n\nUses of LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 is primarily used for the treatment and management of type 2 diabetes mellitus in adults. It helps maintain proper blood sugar levels and supports long-term metabolic health.\n\n1. Management of Type 2 Diabetes\n\nThis medication is prescribed to help control blood sugar levels in individuals diagnosed with type 2 diabetes when lifestyle modifications alone are not enough.\n\n2. Improvement of Glycemic Control\n\nThe dual mechanism of action helps regulate both fasting and post-meal blood glucose levels, improving overall glycemic control.\n\n3. Prevention of Diabetes Complications\n\nProper management of blood sugar levels helps reduce the risk of diabetes-related complications such as nerve damage, kidney problems, eye disorders, and cardiovascular disease.\n\n4. Support for Insulin Sensitivity\n\nMetformin helps improve the body's response to insulin, making it easier for cells to utilize glucose efficiently.\n\nKey Benefits of LINALIGOLD M 2.5/1000\n1. Dual Mechanism for Better Blood Sugar Control\n\nThe combination of Metformin and Linagliptin provides a two-way approach to controlling blood glucose levels by addressing multiple pathways involved in glucose metabolism.\n\n2. Helps Maintain Stable Blood Sugar Levels\n\nLINALIGOLD M 2.5/1000 helps regulate blood sugar throughout the day, including after meals when glucose levels tend to spike.\n\n3. Supports Natural Insulin Activity\n\nLinagliptin enhances the body's natural insulin response without forcing the pancreas to overwork.\n\n4. Reduces Risk of Blood Sugar Spikes\n\nBy controlling glucose production in the liver and improving insulin efficiency, the medication helps prevent sudden increases in blood sugar.\n\n5. Improves Overall Metabolic Health\n\nRegular use, along with proper diet and exercise, supports better metabolic balance and energy utilization in the body.\n\n6. Convenient Combination Therapy\n\nInstead of taking multiple medications separately, this fixed-dose combination simplifies diabetes management and improves treatment adherence.\n\n7. Lower Risk of Hypoglycemia\n\nCompared with some other diabetes medications, Linagliptin generally carries a lower risk of causing dangerously low blood sugar levels when used appropriately.\n\nHow to Use LINALIGOLD M 2.5/1000\n\nLINALIGOLD M 2.5/1000 should be taken exactly as prescribed by a healthcare professional.\n\nGeneral usage guidelines include:\n\nTake the tablet with food to reduce stomach discomfort.\n\nSwallow the tablet whole with water; do not crush or chew unless advised.\n\nFollow the dosage and schedule recommended by your doctor.\n\nMaintain a healthy diet and regular physical activity for optimal results.\n\nConsistent use is important for maintaining stable blood sugar levels.\n\nPossible Side Effects\n\nLike all medications, LINALIGOLD M 2.5/1000 may cause side effects in some individuals, although not everyone experiences them. Most side effects are mild and temporary as the body adjusts to the medication.\n\nCommon side effects may include:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nLoss of appetite\n\nMild headache\n\nFatigue\n\nLess common but possible side effects include:\n\nUpper respiratory symptoms such as cough or sore throat\n\nMild skin reactions\n\nVitamin B12 deficiency with long-term use of metformin\n\nRare but serious side effects may include:\n\nSevere allergic reactions\n\nLactic acidosis (a rare but serious condition associated with metformin)\n\nPancreatitis in rare cases related to DPP-4 inhibitors\n\nIf symptoms such as severe abdominal pain, unusual weakness, breathing difficulty, or persistent vomiting occur, medical attention should be sought immediately.\n\nPrecautions\n\nBefore taking LINALIGOLD M 2.5/1000, it is important to consult a healthcare professional, especially if you have:\n\nKidney disease\n\nLiver problems\n\nHeart conditions\n\nHistory of pancreatitis\n\nSevere infections or dehydration\n\nAdditional precautions include:\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about all medications you are currently taking.\n\nRegular blood sugar monitoring is recommended.\n\nLifestyle Recommendations for Better Results\n\nMedication works best when combined with healthy lifestyle practices. Patients using LINALIGOLD M 2.5/1000 are encouraged to:\n\nFollow a balanced diabetic-friendly diet\n\nEngage in regular physical activity\n\nMaintain a healthy body weight\n\nMonitor blood glucose levels regularly\n\nAttend routine medical checkups\n\nThese habits can significantly improve diabetes management and overall health.\n\nConclusion\nType 2 diabetes is a chronic condition that requires consistent and effective management to prevent long-term health complications. LINALIGOLD M 2.5/1000 offers a modern combination therapy that integrates the glucose-lowering effects of metformin with the incretin-enhancing action of Linagliptin, providing a comprehensive approach to blood sugar control.", "price": 154.0, "discountamount": 46.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2323, "imageuri": "https://productimages.withfloats.com/actual/69afcdd9ea5ba715c39c99dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/69afcdd9ea5ba715c39c99dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-03-10T07:52:55.329Z", "updatedon": "2026-03-13T09:13:04.519Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metformin-linagliptin/2323", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGOLD M 2.5/1000", "category": "DIABETIC RANGE", "tags": [ "metformin and linagliptin tablets for diabetes", "metformin linagliptin oral diabetes medication", "linagliptin 2.5 mg metformin 1000 mg tablet", "medicine for type 2 diabetes metformin linagliptin", "best medicine combination for type 2 diabetes", "blood sugar control medicine with metformin", "tablet for fasting and post meal sugar control", "how metformin linagliptin works for diabetes", "metformin linagliptin dosage for type 2 diabetes", "metformin linagliptin tablet price", "linagliptin metformin tablets wholesale price", "LINALIGOLD M metformin linagliptin tablet price", "LINALIGOLD M tablet for type 2 diabetes", "metformin linagliptin tablets india", "linagliptin metformin tablet manufacturer india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699bfe45e844b0fb29d2bbad", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin 100 Pioglitazone 15 Metformin 500", "description": "Product Name: ST GLIPTIN 3D 500\nComposition: Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg\n\nST GLIPTIN 3D 500 is a scientifically formulated triple-combination oral antidiabetic tablet designed to help manage Type 2 Diabetes Mellitus effectively. This advanced formulation combines the proven benefits of Sitagliptin, Pioglitazone, and Metformin to provide comprehensive glycemic control through three complementary mechanisms of action.\n\nThis triple therapy approach is especially beneficial for patients whose blood glucose levels are not adequately controlled with dual therapy or monotherapy. ST GLIPTIN 3D 500 is developed to address multiple metabolic defects associated with Type 2 diabetes, ensuring better long-term glucose management and improved patient outcomes.\n\nProduct Description\n\nST GLIPTIN 3D 500 is an oral antidiabetic medication that works by targeting different physiological pathways involved in glucose regulation:\n\nSitagliptin 100 mg enhances incretin hormone levels, which increase insulin release and decrease glucagon secretion in a glucose-dependent manner.\n\nPioglitazone 15 mg improves insulin sensitivity in muscle and adipose tissues, allowing the body to use insulin more effectively.\n\nMetformin 500 mg reduces hepatic glucose production and improves peripheral glucose uptake.\n\nBy combining these three well-established agents into a single tablet, ST GLIPTIN 3D 500 simplifies diabetes management while improving adherence and therapeutic efficiency.\n\nUses of ST GLIPTIN 3D 500\n\nST GLIPTIN 3D 500 is primarily indicated for:\n\nManagement of Type 2 Diabetes Mellitus\n\nImproving glycemic control in adults\n\nPatients inadequately controlled on metformin alone\n\nIndividuals requiring triple oral therapy\n\nReducing fasting and postprandial blood glucose levels\n\nSupporting long-term HbA1c reduction\n\nIt is typically prescribed alongside lifestyle modifications such as a healthy diet, regular exercise, and weight management.\n\nHow ST GLIPTIN 3D 500 Works\n\nType 2 diabetes is characterized by insulin resistance, decreased insulin secretion, and excessive hepatic glucose production. ST GLIPTIN 3D 500 addresses all three core defects:\n\nEnhances insulin secretion (Sitagliptin) – Works in a glucose-dependent manner, reducing risk of hypoglycemia.\n\nImproves insulin sensitivity (Pioglitazone) – Helps the body respond better to insulin.\n\nReduces glucose production (Metformin) – Decreases sugar release from the liver.\n\nThis comprehensive mechanism makes ST GLIPTIN 3D 500 a powerful therapeutic option for sustained glycemic control.\n\nKey Benefits of ST GLIPTIN 3D 500\n1. Triple Mechanism Advantage\n\nCombines three different classes of antidiabetic agents for broader and more effective blood sugar management.\n\n2. Improved HbA1c Reduction\n\nHelps significantly lower HbA1c levels when compared to monotherapy.\n\n3. Reduced Pill Burden\n\nThree medications in one tablet improve patient compliance and convenience.\n\n4. Better Postprandial Control\n\nHelps manage blood glucose spikes after meals.\n\n5. Insulin Sensitivity Enhancement\n\nPioglitazone improves peripheral glucose utilization.\n\n6. Lower Risk of Hypoglycemia\n\nSitagliptin works in a glucose-dependent manner, minimizing low blood sugar risk when used appropriately.\n\n7. Suitable for Long-Term Management\n\nDesigned for chronic use under medical supervision.\n\nDosage and Administration\n\nThe dosage should be taken strictly as prescribed by a healthcare professional.\n\nUsually administered once daily with meals to reduce gastrointestinal discomfort.\n\nSwallow the tablet whole with water.\n\nDo not crush or chew unless directed by a doctor.\n\nRegular monitoring of blood glucose and HbA1c levels is recommended during therapy.\n\nPossible Side Effects\n\nLike all medications, ST GLIPTIN 3D 500 may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nNausea\n\nDiarrhea\n\nStomach discomfort\n\nHeadache\n\nUpper respiratory symptoms\n\nLess Common but Important:\n\nWeight gain (associated with Pioglitazone)\n\nFluid retention or edema\n\nLow blood sugar (when combined with other antidiabetic agents)\n\nVitamin B12 deficiency (long-term Metformin use)\n\nRare but Serious:\n\nLactic acidosis (rare, associated with Metformin)\n\nPancreatitis (rare, associated with Sitagliptin)\n\nLiver function abnormalities\n\nPatients should immediately consult a healthcare provider if they experience severe abdominal pain, persistent vomiting, unusual swelling, or breathing difficulties.\n\nPrecautions and Warnings\n\nNot recommended for Type 1 diabetes.\n\nUse cautiously in patients with renal impairment.\n\nLiver function monitoring may be required.\n\nAvoid excessive alcohol consumption.\n\nInform your doctor about any existing heart conditions.\n\nPregnant or breastfeeding women should use this medication only if clearly advised by a healthcare professional.\n\nStorage Instructions\n\nStore below 25°C in a dry place.\n\nKeep away from direct sunlight.\n\nKeep out of reach of children.\n\nWhy Choose ST GLIPTIN 3D 500?\n\nST GLIPTIN 3D 500 stands out as a comprehensive diabetes management solution by combining three powerful and clinically established molecules in one convenient tablet. It is particularly beneficial for patients who require intensified glycemic control without increasing pill burden.\n\nThe triple therapy model helps target multiple metabolic dysfunctions simultaneously, offering better blood glucose stability throughout the day. When used as part of a complete diabetes management plan—including diet, exercise, and routine monitoring—ST GLIPTIN 3D 500 can significantly enhance quality of life and reduce long-term complications associated with uncontrolled diabetes.\n\nConclusion\nST GLIPTIN 3D 500 (Sitagliptin 100 mg + Pioglitazone 15 mg + Metformin 500 mg) represents a modern, evidence-based approach to managing Type 2 Diabetes Mellitus. By addressing insulin resistance, impaired insulin secretion, and excessive glucose production, it provides comprehensive and sustained glycemic control.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2311, "imageuri": "https://productimages.withfloats.com/actual/699bfe47d849febb9bcc2d46.png", "tileimageuri": "https://productimages.withfloats.com/tile/699bfe47d849febb9bcc2d46.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-23T07:14:13.494Z", "updatedon": "2026-03-13T11:04:02.141Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-100-pioglitazone-15-metformin-500/2311", "availableunits": -1.0, "iscodavailable": true, "isprepaidonlineavailable": true, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN 3D 500", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 100 Pioglitazone 15 Metformin 500 tablet uses", "Sitagliptin Pioglitazone Metformin triple therapy dosage", "Sitagliptin 100 mg Pioglitazone 15 mg Metformin 500 mg benefits", "Triple combination tablet for type 2 diabetes control", "Sitagliptin Pioglitazone Metformin side effects in adults", "How to take Sitagliptin Pioglitazone Metformin tablet", "Sitagliptin Metformin Pioglitazone price in India", "Buy Sitagliptin 100 Pioglitazone 15 Metformin 500 online", "Order Sitagliptin Pioglitazone Metformin tablets", "Sitagliptin 100 Pioglitazone 15 Metformin 500 price", "Sitagliptin triple combination bulk purchase" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "694e56c05837f90c86a7eb8c", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "empagliflozin linagliptin and metformin", "description": "LINALIGIP EMPAMET (Empagliflozin, Linagliptin, and Metformin Hydrochloride ER Tablets) stands out as a comprehensive triple therapy for adults with type 2 diabetes mellitus, combining three synergistic agents to tackle hyperglycemia from multiple angles. This once-daily extended-release formulation simplifies adherence while delivering robust glycemic control, weight management, and cardiovascular protection. Patients often seek it for its convenience in managing blood sugar levels when diet, exercise, and single agents fall short.\n​\n\nProduct Description and Composition\nLINALIGIP EMPAMET features Empagliflozin (typically 10-25mg), Linagliptin (5 mg), and Metformin Hydrochloride ER (up to 1000mg) in a single tablet, designed for prolonged release to minimize gastrointestinal upset. Empagliflozin, an SGLT2 inhibitor, blocks glucose reabsorption in the kidneys, promoting its excretion via urine. Linagliptin, a DPP-4 inhibitor, enhances incretin hormones like GLP-1 to boost insulin secretion and suppress glucagon. Metformin ER reduces hepatic glucose production and improves insulin sensitivity without hypoglycemia risk.\n​\n\nThis unique blend from Steris Healthcare ensures steady drug delivery over 24 hours, reducing peak-trough fluctuations for stable HbA1c reductions of 1.5-2.0%. The extended-release metformin coats the tablet core, dissolving gradually in the intestines for better tolerability compared to immediate-release forms. Ideal for Indian patients facing rising diabetes prevalence, it addresses insulin resistance, postprandial spikes, and caloric overload holistically.\n​\n\nMechanism of Action\nThe triple mechanism targets key diabetes pathways: Empagliflozin inhibits SGLT2 in proximal renal tubules, lowering blood glucose by 70-90g daily through glycosuria, independent of insulin. Linagliptin selectively binds DPP-4, prolonging GLP-1 and GIP activity to stimulate glucose-dependent insulin release from beta cells and curb glucagon-mediated gluconeogenesis. Metformin activates AMPK in hepatocytes, inhibiting gluconeogenesis while enhancing peripheral glucose uptake.\n​\n\nSynergy amplifies effects—SGLT2 inhibition provides insulin-independent control, DPP-4 boosts prandial responses, and metformin tackles fasting hyperglycemia—resulting in complementary HbA1c drops without overlapping toxicities. Clinical data show this combination yields superior efficacy over dual therapies, with added osmotic diuresis aiding fluid balance.\n​\n\nUses and Indications\nLINALIGIP EMPAMET treats type 2 diabetes in adults, as adjunct to diet and exercise, especially when metformin alone or dual therapy inadequately controls glycemia. Primary uses include newly diagnosed patients needing intensification, those with obesity (due to weight loss from glycosuria), and high-risk cardiovascular profiles benefiting from empagliflozin's heart protection. It excels in managing postprandial hyperglycemia, fasting glucose, and preventing complications like nephropathy.\n​\n\nPrescribed for patients intolerant to other agents or requiring simplified regimens, it suits Indian demographics with high metabolic syndrome rates. Not for type 1 diabetes or ketoacidosis; renal function (eGFR >45 mL/min) guides initiation.\n​\n\nKey Benefits\nLINALIGIP EMPAMET offers multifaceted advantages for long-term diabetes management:\n\nSuperior Glycemic Control: Achieves 1.8% HbA1c reduction in trials, outperforming monotherapies by targeting multiple defects.\n​\n\nWeight Loss: Empagliflozin induces 3-5kg loss via caloric excretion, countering metformin's neutral effect.\n​\n\nCardiovascular and Renal Protection: Reduces major adverse cardiac events (MACE) by 14% and slows CKD progression, per EMPA-REG outcomes.\n​\n\nLow Hypoglycemia Risk: Glucose-dependent actions of linagliptin and empagliflozin minimize lows, unlike sulfonylureas.\n​\n\nConvenience: Single-tablet ER dosing improves compliance, vital for busy lifestyles in Jaipur and beyond.\n​\n\nBlood Pressure Reduction: Mild diuretic effect lowers systolic BP by 3-5 mmHg.\n​\n\nThese benefits enhance quality of life, reducing fatigue, neuropathy risks, and healthcare costs.\n\nSide Effects\nCommon side effects mirror individual components but occur less due to synergy:\n\nGastrointestinal: Metformin ER causes less nausea/diarrhea (10-15%) than IR forms; titrate slowly.\n​\n\nGenitourinary: Empagliflozin raises UTI/genital mycotic infection risk (5-10%), managed with hygiene.\n​\n\nVolume Depletion: Orthostatic hypotension in 2-3%, especially with diuretics.\n​\n\nSerious effects include lactic acidosis (rare, <1/100,000 with metformin in eGFR >30), ketoacidosis (euglycemic, 0.1%), and acute kidney injury. Monitor for dehydration, pancreatitis signs, or bullous pemphigoid with linagliptin. Hypersensitivity rash or bone fractures warrant discontinuation.\n​\n\nSide Effect Category\tFrequency\tManagement\nNausea and Diarrhea\tCommon (10%)\tTake with food, slow titration \n​\nUTI/Mycotic Infections\tCommon (7%)\tHydration, antifungals \n​\nHypoglycemia\tRare (<2%)\tWith insulin, dose adjust \n​\nLactic Acidosis\tVery Rare.\tAvoid in renal/hepatic failure \n​\nKetoacidosis\tRare (0.1%)\tCheck ketones if nausea \n​\nDosage and Administration\nStart with Empagliflozin 10mg/Linagliptin 5mg/Metformin ER 1000mg once daily with morning meal to optimize absorption and reduce GI effects. Titrate metformin to 2000mg max based on tolerance; empagliflozin to 25mg if needed. Swallow whole; no crushing. Adjust for renal impairment (eGFR 30-45: max metformin 1000mg; <30 contraindicated). Elderly start low due to volume sensitivity.\n​\n\nMissed dose: Take soon if less than 12 hours late; skip otherwise. Discontinue pre-surgery or contrast use.\n\nPrecautions and Warnings\nAssess eGFR before and 3-6 months after initiation; hold if <45. Caution in dehydration, heart failure, or liver disease risks lactic acidosis. Educate on ketoacidosis symptoms (nausea, fatigue) despite normal glucose. Avoid excessive alcohol; monitor BP in hypertensives. Pregnancy category D—use insulin instead. Breastfeeding is contraindicated.\n​\n\nDrug interactions: Adding sulfonylureas/insulin heightens hypoglycemia; rifampin reduces linagliptin levels; ritonavir boosts empagliflozin exposure.\n\nFrequently Asked Questions\nWhat is LINALIGIP EMPAMET used for?\nControls type 2 diabetes via triple action on glucose excretion, incretins, and insulin sensitivity.\n​\nDoes it cause weight gain?\nNo—it promotes 2-4 kg loss, unlike some antidiabetics.\n​\n\nSafe for kidneys?\nRenal-protective; monitor eGFR.\n​\n\nHypoglycemia risk?\nMinimal without sulfonylureas.\n\nConclusion\nLINALIGIP EMPAMET revolutionizes type 2 diabetes care with its potent, convenient triple therapy, delivering glycemic mastery, weight benefits, and cardioprotection unmatched by singles or duos. Backed by landmark trials, it empowers patients toward complication-free lives when integrated with lifestyle changes. Consult physicians for personalized dosing to harness its full potential safely.", "price": 220.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2257, "imageuri": "https://productimages.withfloats.com/actual/694e60c1db6d50f75e42e875.png", "tileimageuri": "https://productimages.withfloats.com/tile/694e60c1db6d50f75e42e875.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-26T09:34:56.604Z", "updatedon": "2026-03-13T10:59:31Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-linagliptin-and-metformin/2257", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LINALIGIP EMPAMET", "category": "DIABETIC RANGE", "tags": [ "empagliflozin 10 mg", "empagliflozin 25 mg", "empagliflozin 10 mg uses in hindi", "empagliflozin 10 mg tablet.", "type 2 diabetes mellitus.", "linagliptin", "Linagliptin 5 mg", "linagliptin 5 mg uses", "linagliptin tablet uses", "Linagliptin 5 mg price", "Empagliflozin, an SGLT2 inhibitor.", "Metformin ER reduces hepatic glucose production and improves insulin.", "LINALIGIP EMPAMET revolutionizes type 2 diabetes.", "empagliflozin linagliptin and metformin tablets", "empagliflozin linagliptin metformin combination tablet", "empagliflozin linagliptin metformin tablets uses", "empagliflozin linagliptin metformin triple combination", "empagliflozin linagliptin metformin dosage strength", "empagliflozin linagliptin metformin sustained release tablet", "empagliflozin linagliptin metformin medicine for diabetes", "empagliflozin linagliptin metformin tablet uses", "empagliflozin linagliptin metformin benefits", "empagliflozin linagliptin metformin for type 2 diabetes", "empagliflozin linagliptin metformin blood sugar control", "empagliflozin linagliptin metformin weight loss benefit", "what is empagliflozin linagliptin metformin tablet", "how does empagliflozin linagliptin metformin work", "empagliflozin linagliptin metformin tablet price in india", "empagliflozin linagliptin metformin tablet dosage", "empagliflozin linagliptin metformin before or after food" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6932959513286b8c66d8786f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Myoinositol 600mg + Metformin SR 500", "description": "OVOCYST M is a specialized sustained-release tablet combining Myoinositol 600mg and Metformin SR 500mg, primarily designed to address polycystic ovary syndrome (PCOS) and related metabolic issues in women. This formulation from Steris Healthcare Pvt Ltd targets insulin resistance, hormonal imbalances, and ovulatory dysfunction, making it a go-to option for restoring reproductive wellness. By improving insulin sensitivity and ovarian function, OVOCYST M supports regular cycles and fertility outcomes effectively.​\n\nProduct Composition and Mechanism\nOVOCYST M features Myoinositol 600mg, a natural insulin signaling mediator that enhances cellular health and oocyte quality in PCOS patients. Paired with Metformin SR 500mg, a sustained-release biguanide that lowers hepatic glucose production and boosts peripheral insulin uptake, this duo tackles root causes like hyperinsulinemia. The SR technology ensures gradual release, minimizing digestive upset while providing prolonged metabolic support throughout the day.​\n\nThis synergistic action restores ovulatory cycles by balancing hormones such as FSH and LH, reducing androgen excess common in PCOS. Women experiencing anovulation or irregular menses find OVOCYST M particularly beneficial as it promotes follicular development without aggressive interventions.​\n\nKey Uses of OVOCYST M\nOVOCYST M excels in managing PCOS symptoms, including irregular menstrual cycles and infertility linked to insulin resistance. Healthcare providers often prescribe it for hyperandrogenism, where elevated male hormones cause hirsutism or acne, alongside metabolic syndrome features like obesity.​\n\nSupports fertility treatments by improving egg quality and implantation rates in assisted reproduction.​\nAids weight management in PCOS by curbing insulin-driven fat accumulation.​\nRegulates blood sugar in prediabetic women with PCOS, preventing progression to type 2 diabetes.​\nTypically taken once or twice daily with meals, the dosage aligns with physician guidance for optimal results over 4-12 weeks.​\n\nMajor Benefits for PCOS and Beyond\nOne standout advantage of OVOCYST M is its ability to normalize ovulation, with studies showing improved cycle regularity in up to 70-80% of users. By enhancing insulin sensitivity, it reduces hyperinsulinemia, alleviating symptoms like fatigue and cravings that hinder daily life.​\n\nPromotes modest weight loss (2-5kg over months) through better metabolic control, boosting self-esteem and mobility.​\n\nEnhances fertility by maturing oocytes and lowering miscarriage risks in PCOS pregnancies.​\n\nLowers androgen levels, clearing skin issues and reducing unwanted hair growth for aesthetic and emotional relief.​\n\nLong-term use under supervision sustains these gains, fostering holistic health improvements like better energy and mood stability.​\n\nPotential Side Effects and Precautions\nWhile generally well-tolerated, OVOCYST M may cause mild gastrointestinal effects such as nausea, flatulence, or a metallic taste from Metformin. These often subside with time or food intake, thanks to the SR formulation's gentler profile.​\n\nRare but serious risks include lactic acidosis in those with kidney/liver issues, warranting avoidance in such cases. Precautions involve monitoring blood sugar, avoiding during acute illnesses, and consulting doctors if pregnant or breastfeeding.​\n\nCommon: Bloating or diarrhea, manageable by starting low dose.​\n\nConsult promptly for persistent vomiting or weakness.​\n\nConclusion\nOVOCYST M stands as a reliable, science-backed ally for women battling PCOS, insulin resistance, and fertility hurdles through its potent Myoinositol 600mg and Metformin SR 500mg blend. Delivering tangible benefits like restored cycles, weight control, and enhanced conception chances, it empowers proactive reproductive health management. Always pair with lifestyle tweaks like balanced diet and exercise for peak efficacy, and rely on professional oversight for safe, sustained results—transforming challenges into opportunities for vitality.", "price": 257.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2233, "imageuri": "https://productimages.withfloats.com/actual/693295fa395d93bf6f980d94.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/693295fa395d93bf6f980d94.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-05T08:19:33.812Z", "updatedon": "2026-03-26T06:02:58.674Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//myoinositol-600mg-metformin-sr-500/2233", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OVOCYST M", "category": "GYANECOLOGYRANGE", "tags": [ "Myoinositol 600mg and Metformin SR 500mg", "polycystic ovary syndrome (PCOS)", "OVOCYST M supports regular cycles and fertility" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "691437f0df62fb2c61ddbc40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ginkgo Biloba Extract and Piracetam Tablets ", "description": "Ginkgo Biloba Extract & Piracetam Tablets is a scientifically formulated neuroprotective and cognitive-enhancing combination designed to support memory, concentration, and brain function. It combines two powerful agents — Ginkgo Biloba, a time-tested herbal extract known for its circulation-enhancing and antioxidant properties, and Piracetam, a well-researched nootropic compound that enhances neuronal communication and cognitive performance.\n\nTogether, these two active ingredients work synergistically to improve cerebral blood flow, increase oxygen and nutrient delivery to the brain, and enhance mental clarity and alertness. The formulation is widely prescribed as a neurotonic and cognitive enhancer for individuals experiencing memory decline, age-related cognitive impairment, or neurological disorders such as dementia, Alzheimer’s disease, and cerebrovascular insufficiency.\n\nComposition\n\nEach film-coated tablet typically contains:\n\nGinkgo Biloba Extract (Standardized to contain 24% Flavone Glycosides & 6% Terpene Lactones) – 40 mg or 60 mg\n\nPiracetam – 800 mg\n\nExcipients – q.s.\n\nThe tablets are designed for oral administration, offering convenient dosage and high bioavailability.\n\nMechanism of Action\n1. Ginkgo Biloba Extract\n\nGinkgo Biloba, derived from the leaves of the ancient Ginkgo tree, is rich in flavonoids and terpenoids, which possess antioxidant, vasodilatory, and neuroprotective properties. It acts through several mechanisms:\n\nImproves microcirculation: Enhances blood flow to brain tissues by reducing blood viscosity and promoting vasodilation.\n\nAntioxidant action: Neutralizes free radicals that cause oxidative stress, protecting neurons from damage.\n\nIncreases neurotransmitter activity: Supports the release and uptake of acetylcholine and serotonin, improving mood and memory.\n\nReduces platelet aggregation: Improves oxygen supply to the brain and minimizes risk of ischemic injury.\n\n2. Piracetam\n\nPiracetam is a nootropic (cognitive enhancer) that improves neuronal efficiency and communication between brain cells.\nIts mechanism includes:\n\nEnhancing neuronal plasticity: Facilitates the transmission of impulses across synapses, improving learning and memory.\n\nImproving cerebral blood flow and metabolism: Enhances glucose utilization and oxygen consumption in the brain.\n\nProtecting neurons: Increases membrane fluidity and stabilizes nerve cells against hypoxic or oxidative damage.\n\nTogether, Ginkgo Biloba and Piracetam complement each other to enhance mental performance, protect neural structures, and improve cerebral function.\n\nUses and Indications\n\nGinkgo Biloba Extract & Piracetam Tablets are indicated for the following conditions:\n\nCognitive Decline and Memory Disorders:\n\nImproves memory, focus, and concentration in elderly individuals or those with mild cognitive impairment.\n\nDementia and Alzheimer’s Disease:\n\nUsed as supportive therapy to slow progression of degenerative brain disorders and enhance daily functioning.\n\nCerebrovascular Insufficiency:\n\nBeneficial in cases of reduced blood flow to the brain, helping alleviate symptoms like dizziness, headache, and mental fatigue.\n\nPost-Stroke Rehabilitation:\n\nEnhances neurological recovery and helps restore cognitive function after ischemic brain injury.\n\nVertigo and Tinnitus (Ringing in the Ears):\n\nImproves inner ear circulation, reducing dizziness and balance-related issues.\n\nLearning Disorders and Attention Deficits:\n\nImproves attention span and memory recall in both adults and children.\n\nNeuroprotective Supplement for Elderly:\n\nMaintains brain vitality and helps prevent age-related cognitive decline.\n\nKey Benefits\n\nEnhances Memory and Concentration:\nThe synergistic effect of Ginkgo Biloba and Piracetam improves synaptic transmission and neuroplasticity, enhancing learning, focus, and recall.\n\nBoosts Cerebral Circulation:\nGinkgo Biloba improves microcirculation within brain tissues, ensuring efficient delivery of oxygen and glucose to neurons.\n\nProtects Against Neurodegeneration:\nThe powerful antioxidant activity of flavonoids and terpenes from Ginkgo Biloba helps neutralize harmful free radicals, delaying age-related brain cell damage.\n\nImproves Cognitive Function in Dementia:\nClinical studies have shown improved cognition, mood, and behavior in patients with Alzheimer’s and vascular dementia with this combination.\n\nRestores Energy and Mental Clarity:\nPiracetam enhances brain metabolism and ATP synthesis, combating mental fatigue and promoting alertness.\n\nAids Recovery After Stroke or Brain Injury:\nEnhances neural regeneration, oxygen utilization, and cerebral function in post-stroke rehabilitation.\n\nReduces Dizziness, Vertigo, and Tinnitus:\nGinkgo’s vasodilatory and anti-platelet properties improve blood flow to the inner ear and brain, alleviating these symptoms.\n\nSafe and Well-Tolerated:\nNon-sedating, non-addictive, and suitable for long-term use under medical supervision.\n\nDosage and Administration\n\nAdults: One tablet two or three times daily, or as directed by a physician.\n\nElderly Patients: Dosage may be adjusted according to tolerance and medical condition.\n\nChildren: Use only if prescribed by a doctor.\n\nTablets should be swallowed whole with water, preferably after meals to avoid gastrointestinal discomfort.\n\nPrecautions and Warnings\n\nMedical Supervision Required: Should only be used under the guidance of a healthcare professional, especially for elderly patients or those on multiple medications.\n\nBleeding Disorders: Ginkgo Biloba may increase bleeding risk; avoid in patients with clotting disorders or those taking anticoagulants.\n\nSurgery: Discontinue use at least two weeks before scheduled surgery to minimize bleeding risk.\n\nEpilepsy: Piracetam may lower the seizure threshold; caution advised in epileptic patients.\n\nPregnancy and Lactation: Safety not well established; use only if prescribed by a doctor.\n\nDriving or Operating Machinery: Some individuals may experience dizziness or drowsiness; caution advised.\n\nPossible Side Effects\n\nWhile generally safe, Ginkgo Biloba Extract & Piracetam Tablets may cause mild, transient side effects in some users. These typically resolve upon dosage adjustment or discontinuation.\n\nCommon Side Effects:\n\nHeadache or mild dizziness\n\nNausea or stomach discomfort\n\nNervousness or restlessness\n\nInsomnia (if taken late in the day)\n\nLess Common Side Effects:\n\nAllergic skin rash or itching\n\nGastrointestinal upset\n\nPalpitations or rapid heartbeat\n\nMild bleeding (nosebleed, bruising) in sensitive individuals\n\nTremors (rare, usually at higher doses)\n\nSeek medical help immediately if severe allergic reactions, confusion, or unusual bleeding occur.\n\nDrug Interactions\n\nAnticoagulants and Antiplatelet Agents (e.g., Warfarin, Aspirin): May increase bleeding risk.\n\nNSAIDs (e.g., Ibuprofen): Combined use may enhance bleeding tendency.\n\nAntiepileptic Medications: Use with caution as Piracetam may affect seizure control.\n\nHerbal Supplements (e.g., Garlic, Ginseng): May potentiate anticoagulant effects.\n\nStorage and Handling\n\nStore below 30°C, protected from moisture and direct sunlight.\n\nKeep out of reach of children.\n\nDo not use tablets past the expiry date or if the blister pack is damaged.\n\nConclusion\n\nGinkgo Biloba Extract & Piracetam Tablets represent a powerful blend of herbal wisdom and modern neuroscience, formulated to promote optimal brain function and long-term cognitive health. By enhancing blood circulation to the brain, protecting neurons from oxidative damage, and improving neurotransmitter activity, this combination supports memory, focus, and mental agility across all age groups.\n\nIdeal for individuals suffering from age-related memory loss, stress-induced mental fatigue, or neurological disorders, this formulation provides comprehensive neuroprotection and cognitive enhancement in a safe, well-tolerated form.", "price": 250.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2203, "imageuri": "https://productimages.withfloats.com/actual/691437f3b2490379b1b47e37.png", "tileimageuri": "https://productimages.withfloats.com/tile/691437f3b2490379b1b47e37.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-12T07:32:00.682Z", "updatedon": "2026-03-13T06:57:24.484Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ginkgo-biloba-extract-and-piracetam-tablets-/2203", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PATRICETAM GINKOBA", "category": "NEUROLOGY RANGE", "tags": [ "ginkgo biloba extract and piracetam tablet uses", "ginkgo biloba with piracetam benefits", "ginkgo biloba and piracetam for memory support", "ginkgo biloba piracetam dosage guide", "ginkgo biloba piracetam side effects", "ginkgo biloba piracetam combination therapy", "buy ginkgo biloba piracetam tablets online", "ginkgo biloba piracetam tablet price", "ginkgo biloba piracetam bulk order", "ginkgo biloba piracetam export supplier", "ginkgo biloba extract 60mg with piracetam tablets", "ginkgo biloba piracetam nootropic combination tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68fcb453ba48b3ee8857fd47", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin Phosphate Monhydrate 64.25 mg, Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg & Glimepirde 1 mg", "description": "ST GLIPTIN GM is a high-quality, fixed-dose combination oral antidiabetic medication containing Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg. This triple-combination therapy is specifically formulated to provide effective glycemic control in adults with type 2 diabetes mellitus (T2DM) who require multiple agents to achieve adequate blood sugar control.\nST GLIPTIN GM works through complementary mechanisms to target the core pathophysiological defects of T2DM—insulin resistance, impaired insulin secretion, and increased hepatic glucose output—making it an ideal choice for patients requiring intensified therapy.\nKey Indications:\nST GLIPTIN GM is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when dual therapy with any two of the individual components (Sitagliptin, Metformin, or Glimepiride) does not provide adequate control.\nMechanism of Action:\nSitagliptin (50 mg):\nA Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances the levels of active incretin hormones (GLP-1 and GIP), increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner.\nMetformin Hydrochloride (1000 mg):\nA biguanide that improves insulin sensitivity by decreasing hepatic glucose production and enhancing peripheral glucose uptake.\nGlimepiride (1 mg):\nA sulfonylurea that stimulates pancreatic β-cells to secrete insulin, thereby reducing blood glucose levels.\nThe combination targets multiple metabolic pathways to provide synergistic and sustained blood glucose control.\nDosage and Administration:\nRecommended Dose:\nOne tablet daily, preferably with meals to reduce gastrointestinal side effects.\nIndividualization Required:\nDosage should be tailored based on patient response, renal function, and physician assessment.\nRenal Monitoring:\nBaseline and periodic assessment of renal function is advised, particularly due to the metformin component.\nKey Benefits of ST GLIPTIN GM 50/1000/1:\nTriple Mechanism of Action:\nTargets insulin resistance, insufficient insulin secretion, and excessive hepatic glucose production.\nEnhanced Glycemic Control:\nEffective in achieving and maintaining HbA1c targets.\nOnce-Daily Convenience:\nImproves adherence by reducing pill burden in patients requiring combination therapy.\nWeight Neutral to Modest Reduction:\nMetformin and sitagliptin components support weight neutrality.\nLow Hypoglycemia Risk:\nSitagliptin and metformin carry minimal hypoglycemia risk; however, glimepiride may increase the risk—monitor accordingly.\nSafety and Precautions:\nHypoglycemia:\nMay occur, particularly due to the glimepiride component. Educate patients on recognizing and managing low blood sugar.\nLactic Acidosis:\nA rare but serious complication of metformin. Avoid in patients with significant renal impairment or conditions predisposing to hypoxia.\nRenal Function:\nDose adjustment or discontinuation may be needed based on renal function.\nPancreatitis:\nRare reports with DPP-4 inhibitors like sitagliptin. Discontinue if suspected.\nAllergic Reactions:\nDiscontinue use if hypersensitivity reactions occur.\nPossible Side Effects:\nWhile ST GLIPTIN GM is generally well-tolerated, some patients may experience:\nNausea\nDiarrhea\nHeadache\nHypoglycemia (especially in elderly or with missed meals)\nAbdominal discomfort\nUpper respiratory tract infections\nDizziness\nFlatulence\nIf any side effects persist or worsen, seek immediate medical advice.\nStorage Instructions:\nStore at a temperature below 30°C.\nProtect from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose ST GLIPTIN GM 50/1000/1?\nST GLIPTIN GM provides a powerful and synergistic combination of three well-established antidiabetic agents in a single, convenient daily dose. It offers a comprehensive approach to managing type 2 diabetes by addressing multiple metabolic abnormalities with a focus on safety, efficacy, and patient compliance. Manufactured under stringent GMP-certified conditions, ST GLIPTIN GM ensures quality, reliability, and therapeutic confidence for both patients and prescribers.", "price": 285.0, "discountamount": 86.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2188, "imageuri": "https://productimages.withfloats.com/actual/68fcb456f31288eaa96accfa.png", "tileimageuri": "https://productimages.withfloats.com/tile/68fcb456f31288eaa96accfa.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-25T11:28:19.425Z", "updatedon": "2026-03-13T10:40:20.1Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//sitagliptin-phosphate-monhydrate-64-25-mg-sitagliptin-50-mg-metformin-hydrochloride-1000-mg-glimepirde-1-mg/2188", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM 50+1000+1", "category": "DIABETIC RANGE", "tags": [ "Sitagliptin 50 mg", "Sitagliptin 50 mg, Metformin Hydrochloride 1000 mg, and Glimepiride 1 mg", "type 2 diabetes mellitus (T2DM)", "blood sugar control" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "glimepiride voglibose metformin", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/69abe998ad5b8f3f9ba863c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/69abe998ad5b8f3f9ba863c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2026-03-13T10:35:41.824Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glimepiride-voglibose-metformin/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "DIABETIC RANGE", "tags": [ "glimepiride voglibose metformin tablets", "glimepiride voglibose metformin combination", "glimepiride voglibose metformin dosage", "glimepiride voglibose metformin uses", "glimepiride voglibose metformin composition", "glimepiride voglibose metformin tablets ip", "glimepiride voglibose metformin triple combination", "glimepiride voglibose metformin for type 2 diabetes", "triple drug combination for type 2 diabetes", "diabetes medicine for high fasting and pp sugar", "medicine for uncontrolled diabetes type 2", "combination tablets for diabetes management", "combination tablets for diabetes management", "when to take glimepiride voglibose metformin tablets", "who should take glimepiride voglibose metformin", "benefits of glimepiride voglibose metformin tablets", "side effects of glimepiride voglibose metformin" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }

Still searching for
glucose uptake?

Still searching for
glucose uptake?

Chat with us